LQDA
Price
$23.95
Change
+$1.09 (+4.77%)
Updated
Oct 7, 02:37 PM (EDT)
Capitalization
1.97B
35 days until earnings call
NUVL
Price
$83.07
Change
-$0.78 (-0.93%)
Updated
Oct 7, 01:59 PM (EDT)
Capitalization
6.05B
30 days until earnings call
Interact to see
Advertisement

LQDA vs NUVL

Header iconLQDA vs NUVL Comparison
Open Charts LQDA vs NUVLBanner chart's image
Liquidia
Price$23.95
Change+$1.09 (+4.77%)
Volume$15.16K
Capitalization1.97B
Nuvalent
Price$83.07
Change-$0.78 (-0.93%)
Volume$100
Capitalization6.05B
LQDA vs NUVL Comparison Chart in %
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LQDA vs. NUVL commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LQDA is a Hold and NUVL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (LQDA: $22.86 vs. NUVL: $83.85)
Brand notoriety: LQDA and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LQDA: 75% vs. NUVL: 106%
Market capitalization -- LQDA: $1.97B vs. NUVL: $6.05B
LQDA [@Biotechnology] is valued at $1.97B. NUVL’s [@Biotechnology] market capitalization is $6.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LQDA’s FA Score shows that 1 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • LQDA’s FA Score: 1 green, 4 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, LQDA is a better buy in the long-term than NUVL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LQDA’s TA Score shows that 4 TA indicator(s) are bullish while NUVL’s TA Score has 7 bullish TA indicator(s).

  • LQDA’s TA Score: 4 bullish, 6 bearish.
  • NUVL’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, NUVL is a better buy in the short-term than LQDA.

Price Growth

LQDA (@Biotechnology) experienced а +0.26% price change this week, while NUVL (@Biotechnology) price change was -1.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.92%. For the same industry, the average monthly price growth was +16.20%, and the average quarterly price growth was +89.35%.

Reported Earning Dates

LQDA is expected to report earnings on Nov 11, 2025.

NUVL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+7.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($6.05B) has a higher market cap than LQDA($1.97B). LQDA YTD gains are higher at: 94.388 vs. NUVL (7.115). LQDA has higher annual earnings (EBITDA): -133.4M vs. NUVL (-362.01M). NUVL has more cash in the bank: 1.01B vs. LQDA (173M). LQDA has higher revenues than NUVL: LQDA (19.3M) vs NUVL (0).
LQDANUVLLQDA / NUVL
Capitalization1.97B6.05B33%
EBITDA-133.4M-362.01M37%
Gain YTD94.3887.1151,327%
P/E RatioN/AN/A-
Revenue19.3M0-
Total Cash173M1.01B17%
Total Debt200MN/A-
FUNDAMENTALS RATINGS
LQDA: Fundamental Ratings
LQDA
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
18
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LQDANUVL
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 7 days ago
85%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 13 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NOEMX14.57N/A
N/A
Northern Emerging Markets Equity Index
MUXAX29.17N/A
N/A
Victory S&P 500 Index A
JMGFX57.41N/A
N/A
JPMorgan Mid Cap Growth R5
AGLOX15.82N/A
N/A
Ariel Global Investor
BLADX9.74-0.02
-0.20%
BlackRock Managed Income Investor A